Plough,
''we have a product that will probably be low cost to produce compared to any competition''
All nrt have at present is 3 drug candidates which only have pre clinical findings on mice and test tubes with around $40m to pursue their potential success over the next number of years
The market is up 120 points and yet NRT still at 14.5c
DYOR
- Forums
- ASX - By Stock
- KZA
- Movement
Movement, page-6
-
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online